LLM evaluation for thyroid nodule assessment: comparing ACR-TIRADS, C-TIRADS, and clinician-AI trust gap.

OBJECTIVE

To evaluate the diagnostic performance and clinical utility of advanced large language models (LLMs) -GPT-4o, GPT-o3-mini, and DeepSeek-R1- in stratifying thyroid nodule malignancy risk and generating guideline-aligned management recommendations based on structured narrative ultrasound descriptions.

METHODS

This diagnostic modeling study evaluated three LLMs-GPT-4o, GPT-o3-mini, and DeepSeek-R1-using standardized narrative ultrasound descriptors. These descriptors were annotated by consensus among three senior board-certified sonologists and processed independently in a stateless manner to ensure unbiased outputs. LLM outputs were assessed under both ACR-TIRADS and C-TIRADS frameworks. Two experienced clinicians (a thyroid surgeon and an endocrinologist) independently rated the outputs across five clinical dimensions using 5-point Likert scales. Primary outcomes included the area under the receiver operating characteristic curve (AUC) for malignancy prediction, and clinician ratings of guideline adherence, patient safety, operational feasibility, clinical applicability, and overall performance.

RESULTS

GPT-4o achieved the highest predictive AUC (0.898) under C-TIRADS, approaching expert-level accuracy. DeepSeek-R1, particularly with C-TIRADS, received the highest clinician ratings (mean Likert: surgeon 4.65, endocrinologist 4.63), reflecting greater trust in its practical recommendations. Clinicians consistently favored the C-TIRADS framework across all models. GPT-4o and GPT-o3-mini received lower ratings in trustworthiness and recommendation quality, especially from the endocrinologist.

CONCLUSION

While GPT-4o demonstrated superior diagnostic accuracy, clinicians most trusted DeepSeek-R1 combined with the C-TIRADS framework for generating practical, guideline-consistent recommendations. The findings highlight the critical need for alignment between AI-generated outputs and clinician expectations, and the importance of incorporating region-specific clinical guidelines (like C-TIRADS) for the effective real-world implementation of LLMs in thyroid nodule management decision support.